136 related articles for article (PubMed ID: 36658539)
21. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.
Wang R; Guo XL; Wisman GB; Schuuring E; Wang WF; Zeng ZY; Zhu H; Wu SW
BMC Infect Dis; 2015 Jul; 15():257. PubMed ID: 26142044
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and genotype distribution of HPV and cervical pathological results in Sichuan Province, China: a three years surveys prior to mass HPV vaccination.
Luo Q; Jiang N; Wu Q; Wang J; Zhong J
Virol J; 2020 Jul; 17(1):100. PubMed ID: 32650791
[TBL] [Abstract][Full Text] [Related]
23. [Prevalence and attribution of high-risk HPV in different histological types of cervical cancer].
Wang WP; An JS; Yao HW; Li N; Zhang YY; Ge L; Song Y; Wang MJ; Yuan GW; Sun YC; Huang MN; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):293-300. PubMed ID: 31154709
[No Abstract] [Full Text] [Related]
24. [Crosssectional survey of human papilloma virus subtype distribution and cervical intraepithelial neoplasia in Shenzhen].
Liang LY; Du H; Wang C; Zhang W; Chen Y; Qu XF; Yang B; Wu B; Wu RS; Belinson JL; Wu RF
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Feb; 45(1):114-8. PubMed ID: 23411532
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China.
Li X; Xiang F; Dai J; Zhang T; Chen Z; Zhang M; Wu R; Kang X
Virol J; 2022 Sep; 19(1):146. PubMed ID: 36096810
[TBL] [Abstract][Full Text] [Related]
26. Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province.
Zhang C; Cheng W; Liu Q; Guan Q; Zhang Q
Virol J; 2019 May; 16(1):67. PubMed ID: 31109361
[TBL] [Abstract][Full Text] [Related]
27. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
28. Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.
Ma MJ; Wang YN; Zhu JF; Wang XY; Jin YB; Liu XN; Wu SF; Yang YB
Curr Probl Cancer; 2021 Dec; 45(6):100761. PubMed ID: 34154817
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence of human papilloma virus and analysis of its risk factors in Daqing city, Heilongjiang province in 2010].
Yang L; Li N; Guo LW; Li Q; Cui H; Dai M
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):118-23. PubMed ID: 23719101
[TBL] [Abstract][Full Text] [Related]
30. Impact of HPV vaccination on HPV infection and cervical related disease burden in real-world settings (HPV-RWS): protocol of a prospective cohort.
Liu Z; Li P; Zeng X; Yao X; Sun Y; Lin H; Shen P; Sun F; Zhan S
BMC Public Health; 2022 Nov; 22(1):2117. PubMed ID: 36401179
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grades 1 or worse among 4215 Chinese women in a population-based study.
Zhang R; Velicer C; Chen W; Liaw KL; Wu EQ; Liu B; Cui JF; Belinson JL; Zhang X; Shen GH; Chen F; Qiao YL
Cancer Epidemiol; 2013 Dec; 37(6):939-45. PubMed ID: 24210584
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of human papillomavirus and the correlation of HPV infection with cervical disease in Weihai, China.
Yang L; He Z; Huang XY; Liu HN; Tao JY
Eur J Gynaecol Oncol; 2015; 36(1):73-7. PubMed ID: 25872339
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and genotype distribution of high-risk human papillomavirus in 34 420 cases in Yangzhou city, Jiangsu province, China.
Li Y; Liu X; Han C; Ren C
J Med Virol; 2021 Aug; 93(8):5095-5102. PubMed ID: 33847377
[TBL] [Abstract][Full Text] [Related]
34. [Study on the genotyping of human papillomavirus using a new DNA liquid chip in women of high-risk group of Shandong province].
Liu M; Wang CX; Deng XM; Wang LS; Zhang J; Li W; Zheng GX; Wang JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 May; 28(5):487-90. PubMed ID: 17877181
[TBL] [Abstract][Full Text] [Related]
35. Knowledge of Cervical Cancer, Human Papilloma Virus (HPV) and HPV Vaccination Among Women in Northeast China.
Ning YE; Liu Y; Xu XY; Zhang XY; Wang N; Zheng LQ
J Cancer Educ; 2020 Dec; 35(6):1197-1205. PubMed ID: 31338812
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
37. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
Jain BB; Adhikary T; Sadhukhan PC; Nandi A
J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
[TBL] [Abstract][Full Text] [Related]
38. Epidemiological study of HPV infection in 40,693 women in Putian: a population study based on screening for high-risk HPV infection.
Chen Z; Lin H; Zheng J; Cai L; Chen Z; Li J; Yu L
BMC Infect Dis; 2022 Nov; 22(1):893. PubMed ID: 36443703
[TBL] [Abstract][Full Text] [Related]
39. Single and multiple high-risk and low-risk Human Papillomavirus association with cervical lesions of 11,224 women in Jakarta.
Murdiyarso LS; Kartawinata M; Jenie I; Widjajahakim G; Hidajat H; Sembiring R; Nasar IM; Cornain S; Sastranagara F; Utomo AR
Cancer Causes Control; 2016 Nov; 27(11):1371-1379. PubMed ID: 27752850
[TBL] [Abstract][Full Text] [Related]
40. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
